{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:22:28Z","timestamp":1791588148398,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41401-018-0184-6","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T02:54:48Z","timestamp":1543200888000},"page":"957-970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment"],"prefix":"10.1038","volume":"40","author":[{"given":"Mohamed","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Mahmoud","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagwa Ali","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"184_CR1","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","volume":"2","author":"EA Stewart","year":"2016","unstructured":"Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Prim. 2016;2:16043.","journal-title":"Nat Rev Dis Prim"},{"key":"184_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/biolre\/iox094","volume":"97","author":"M Ali","year":"2017","unstructured":"Ali M, Al-Hendy A. Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids. Biol Reprod. 2017;97:337\u201352.","journal-title":"Biol Reprod"},{"key":"184_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206:e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"184_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.fertnstert.2015.05.031","volume":"104","author":"S Brakta","year":"2015","unstructured":"Brakta S, Diamond JS, Al-Hendy A, Diamond MP, Halder SK. Role of vitamin D in uterine fibroid biology. Fertil Steril. 2015;104:698\u2013706.","journal-title":"Fertil Steril"},{"key":"184_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00438-014-0938-x","volume":"290","author":"SK Halder","year":"2015","unstructured":"Halder SK, Laknaur A, Miller J, Layman LC, Diamond M, Al-Hendy A. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids. Mol Genet Genom. 2015;290:505\u201311.","journal-title":"Mol Genet Genom"},{"key":"184_CR6","first-page":"592","volume":"158","author":"A Al-Hendy","year":"2017","unstructured":"Al-Hendy A, Laknaur A, Diamond MP, Ismail N, Boyer TG, Halder SK. Silencing Med12 gene reduces proliferation of human leiomyoma cells mediated via Wnt\/beta-catenin signaling pathway. Endocrinology. 2017;158:592\u2013603.","journal-title":"Endocrinology"},{"key":"184_CR7","doi-asserted-by":"publisher","first-page":"966","DOI":"10.18632\/oncotarget.370","volume":"2","author":"N Makinen","year":"2011","unstructured":"Makinen N, Heinonen HR, Moore S, Tomlinson IP, van der Spuy ZM, Aaltonen LA. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget. 2011;2:966\u20139.","journal-title":"Oncotarget"},{"key":"184_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine M, Kaasinen E, Makinen N, Katainen R, Kampjarvi K, Pitkanen E, et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013;369:43\u201353.","journal-title":"N Engl J Med"},{"key":"184_CR9","doi-asserted-by":"publisher","first-page":"e33251","DOI":"10.1371\/journal.pone.0033251","volume":"7","author":"MM McGuire","year":"2012","unstructured":"McGuire MM, Yatsenko A, Hoffner L, Jones M, Surti U, Rajkovic A. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS One. 2012;7:e33251.","journal-title":"PLoS ONE"},{"issue":"Suppl 5","key":"184_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1289\/ehp.00108s5775","volume":"108","author":"CC Morton","year":"2000","unstructured":"Morton CC. Genetic approaches to the study of uterine leiomyomata. Environ Health Perspect. 2000;108(Suppl 5):775\u20138.","journal-title":"Environ Health Perspect"},{"key":"184_CR11","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1172\/JCI81534","volume":"125","author":"P Mittal","year":"2015","unstructured":"Mittal P, Shin YH, Yatsenko SA, Castro CA, Surti U, Rajkovic A. Med12 gain-of-function mutation causes leiomyomas and genomic instability. J Clin Invest. 2015;125:3280\u20134.","journal-title":"J Clin Invest"},{"key":"184_CR12","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008;8:957\u201367.","journal-title":"Nat Rev Cancer"},{"key":"184_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tig.2014.06.003","volume":"30","author":"F Dietlein","year":"2014","unstructured":"Dietlein F, Thelen L, Reinhardt HC. Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches. Trends Genet. 2014;30:326\u201339.","journal-title":"Trends Genet"},{"key":"184_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14348\/molcells.2014.2346","volume":"37","author":"AR Venkitaraman","year":"2014","unstructured":"Venkitaraman AR. Tumour suppressor mechanisms in the control of chromosome stability: insights from BRCA2. Mol Cells. 2014;37:95\u20139.","journal-title":"Mol Cells"},{"key":"184_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.molonc.2013.10.005","volume":"8","author":"LD Cassidy","year":"2014","unstructured":"Cassidy LD, Liau SS, Venkitaraman AR. Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation. Mol Oncol. 2014;8:161\u20138.","journal-title":"Mol Oncol"},{"key":"184_CR16","first-page":"69","volume":"94","author":"Q Yang","year":"2016","unstructured":"Yang Q, Nair S, Laknaur A, Ismail N, Diamond MP, Al-Hendy A. The polycomb group protein EZH2 impairs DNA damage repair gene expression in human uterine fibroids. Biol Reprod. 2016;94:69.","journal-title":"Biol Reprod"},{"key":"184_CR17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1177\/1933719116638186","volume":"23","author":"Q Yang","year":"2016","unstructured":"Yang Q, Laknaur A, Elam L, Ismail N, Gavrilova-Jordan L, Lue J, et al. Identification of polycomb group protein EZH2-mediated DNA mismatch repair gene MSH2 in human uterine fibroids. Reprod Sci. 2016;23:1314\u201325.","journal-title":"Reprod Sci"},{"key":"184_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3727\/096504015X14267282610894","volume":"22","author":"X Wu","year":"2014","unstructured":"Wu X, Zhou T, Cao N, Ni J, Wang X. Role of vitamin D metabolism and activity on carcinogenesis. Oncol Res. 2014;22:129\u201337.","journal-title":"Oncol Res"},{"key":"184_CR19","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1038\/onc.2016.77","volume":"35","author":"S Graziano","year":"2016","unstructured":"Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Vitamin D\/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Oncogene. 2016;35:5362\u201376.","journal-title":"Oncogene"},{"key":"184_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/0008-5472.CAN-11-0042","volume":"72","author":"HJ Ting","year":"2012","unstructured":"Ting HJ, Yasmin-Karim S, Yan SJ, Hsu JW, Lin TH, Zeng W, et al. A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D. Cancer Res. 2012;72:958\u201368.","journal-title":"Cancer Res"},{"key":"184_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.18632\/aging.100450","volume":"4","author":"HD Halicka","year":"2012","unstructured":"Halicka HD, Zhao H, Li J, Traganos F, Studzinski GP, Darzynkiewicz Z. Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3. Aging. 2012;4:270\u20138.","journal-title":"Aging"},{"key":"184_CR22","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1210\/jc.2015-3555","volume":"101","author":"A Al-Hendy","year":"2016","unstructured":"Al-Hendy A, Diamond MP, Boyer TG, Halder SK. Vitamin D3 inhibits Wnt\/beta-catenin and mTOR signaling pathways in human uterine fibroid cells. J Clin Endocrinol Metab. 2016;101:1542\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"184_CR23","doi-asserted-by":"publisher","first-page":"E572","DOI":"10.1210\/jc.2014-4011","volume":"100","author":"A Al-Hendy","year":"2015","unstructured":"Al-Hendy A, Diamond MP, El-Sohemy A, Halder SK. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. J Clin Endocrinol Metab. 2015;100:E572\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"184_CR24","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1210\/jc.2010-2131","volume":"96","author":"SK Halder","year":"2011","unstructured":"Halder SK, Goodwin JS, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96:E754\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"184_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1095\/biolreprod.113.107714","volume":"89","author":"SK Halder","year":"2013","unstructured":"Halder SK, Osteen KG, Al-Hendy A. 1,25-dihydroxyvitamin D3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod. 2013;89:150.","journal-title":"Biol Reprod"},{"key":"184_CR26","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/humrep\/det265","volume":"28","author":"SK Halder","year":"2013","unstructured":"Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013;28:2407\u201316.","journal-title":"Hum Reprod"},{"key":"184_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1095\/biolreprod.111.098145","volume":"86","author":"SK Halder","year":"2012","unstructured":"Halder SK, Sharan C, Al-Hendy A. 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod. 2012;86:116.","journal-title":"Biol Reprod"},{"key":"184_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.fertnstert.2010.07.1041","volume":"95","author":"C Sharan","year":"2011","unstructured":"Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril. 2011;95:247\u201353.","journal-title":"Fertil Steril"},{"key":"184_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fgene.2014.00175","volume":"5","author":"J Guirouilh-Barbat","year":"2014","unstructured":"Guirouilh-Barbat J, Lambert S, Bertrand P, Lopez BS. Is homologous recombination really an error-free process? Front Genet. 2014;5:175.","journal-title":"Front Genet"},{"key":"184_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canrad.2011.05.004","volume":"16","author":"E Rass","year":"2012","unstructured":"Rass E, Grabarz A, Bertrand P, Lopez BS. [Double strand break repair, one mechanism can hide another: alternative non-homologous end joining]. Cancer Radiother. 2012;16:1\u201310.","journal-title":"Cancer Radiother"},{"key":"184_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcp.25048","volume":"231","author":"WJ Cannan","year":"2016","unstructured":"Cannan WJ, Pederson DS. Mechanisms and consequences of double-strand DNA break formation in chromatin. J Cell Physiol. 2016;231:3\u201314.","journal-title":"J Cell Physiol"},{"key":"184_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.dnarep.2015.11.019","volume":"38","author":"Z Li","year":"2016","unstructured":"Li Z, Pearlman AH, Hsieh P. DNA mismatch repair and the DNA damage response. DNA Repair (Amst). 2016;38:94\u2013101.","journal-title":"DNA Repair (Amst)"},{"key":"184_CR33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/ijms17040372","volume":"17","author":"E Pawlowska","year":"2016","unstructured":"Pawlowska E, Wysokinski D, Blasiak J. Nucleotide excision repair and vitamin D--relevance for skin cancer therapy. Int J Mol Sci. 2016;17:372.","journal-title":"Int J Mol Sci"},{"key":"184_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc2440","volume":"8","author":"F d\u2019Adda di Fagagna","year":"2008","unstructured":"d\u2019Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008;8:512\u201322.","journal-title":"Nat Rev Cancer"},{"key":"184_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrc2342","volume":"8","author":"T Helleday","year":"2008","unstructured":"Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008;8:193\u2013204.","journal-title":"Nat Rev Cancer"},{"key":"184_CR36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrc2500","volume":"8","author":"JJ Blow","year":"2008","unstructured":"Blow JJ, Gillespie PJ. Replication licensing and cancer--a fatal entanglement? Nat Rev Cancer. 2008;8:799\u2013806.","journal-title":"Nat Rev Cancer"},{"key":"184_CR37","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1128\/JVI.02495-15","volume":"90","author":"WH Chappell","year":"2015","unstructured":"Chappell WH, Gautam D, Ok ST, Johnson BA, Anacker DC, Moody CA. Homologous recombination repair factors Rad51 and BRCA1 are necessary for productive replication of human papillomavirus 31. J Virol. 2015;90:2639\u201352.","journal-title":"J Virol"},{"key":"184_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mrrev.2013.02.001","volume":"753","author":"V Valdiglesias","year":"2013","unstructured":"Valdiglesias V, Giunta S, Fenech M, Neri M, Bonassi S. GammaH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res. 2013;753:24\u201340.","journal-title":"Mutat Res"},{"key":"184_CR39","first-page":"305","volume":"22","author":"LJ Kuo","year":"2008","unstructured":"Kuo LJ, Yang LX. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. Vivo. 2008;22:305\u20139.","journal-title":"Vivo"},{"key":"184_CR40","doi-asserted-by":"publisher","first-page":"101042831769593","DOI":"10.1177\/1010428317695931","volume":"39","author":"VV Palla","year":"2017","unstructured":"Palla VV, Karaolanis G, Katafigiotis I, Anastasiou I, Patapis P, Dimitroulis D, et al. Gamma-H2AX: can it be established as a classical cancer prognostic factor? Tumour Biol. 2017;39:1010428317695931.","journal-title":"Tumour Biol"},{"key":"184_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm3047","volume":"12","author":"TH Stracker","year":"2011","unstructured":"Stracker TH, Petrini JH. The MRE11 complex: starting from the ends. Nat Rev Mol Cell Biol. 2011;12:90\u2013103.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"184_CR42","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.dnarep.2010.10.001","volume":"9","author":"GJ Williams","year":"2010","unstructured":"Williams GJ, Lees-Miller SP, Tainer JA. Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks. DNA Repair (Amst). 2010;9:1299\u2013306.","journal-title":"DNA Repair (Amst)"},{"key":"184_CR43","doi-asserted-by":"publisher","first-page":"10448","DOI":"10.1073\/pnas.1106971108","volume":"108","author":"A Carreira","year":"2011","unstructured":"Carreira A, Kowalczykowski SC. Two classes of BRC repeats in BRCA2 promote RAD51 nucleoprotein filament function by distinct mechanisms. Proc Natl Acad Sci U S A. 2011;108:10448\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"184_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fonc.2014.00106","volume":"4","author":"CE Caldon","year":"2014","unstructured":"Caldon CE. Estrogen signaling and the DNA damage response in hormone dependent breast cancers. Front Oncol. 2014;4:106.","journal-title":"Front Oncol"},{"key":"184_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00428-001-0568-7","volume":"441","author":"D Dixon","year":"2002","unstructured":"Dixon D, Flake GP, Moore AB, He H, Haseman JK, Risinger JI, et al. Cell proliferation and apoptosis in human uterine leiomyomas and myometria. Virchows Arch. 2002;441:53\u201362.","journal-title":"Virchows Arch"},{"key":"184_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0960-0760(01)00177-7","volume":"80","author":"X Wu","year":"2002","unstructured":"Wu X, Blanck A, Olovsson M, Henriksen R, Lindblom B. Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. J Steroid Biochem Mol Biol. 2002;80:77\u201383.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"184_CR47","first-page":"93","volume":"5","author":"M Sabry","year":"2013","unstructured":"Sabry M, Halder SK, Allah AS, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. Int J Women\u2019s Health. 2013;5:93\u2013100.","journal-title":"Int J Women\u2019s Health"},{"key":"184_CR48","doi-asserted-by":"crossref","first-page":"81040","DOI":"10.18632\/oncotarget.18766","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Dong Y, Lu C, Wang Y, Peng L, Jiang M, et al. Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes. Oncotarget. 2017;8:81040\u201351.","journal-title":"Oncotarget"},{"key":"184_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/BJ20110744","volume":"441","author":"JC Fleet","year":"2012","unstructured":"Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J. 2012;441:61\u201376.","journal-title":"Biochem J"},{"issue":"Pt A","key":"184_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jsbmb.2013.09.009","volume":"144","author":"S Gonzalo","year":"2014","unstructured":"Gonzalo S. Novel roles of 1alpha, 25(OH)2D3 on DNA repair provide new strategies for breast cancer treatment. J Steroid Biochem Mol Biol. 2014;144(Pt A):59\u201364.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"184_CR51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/jcb.10338","volume":"88","author":"MF Holick","year":"2003","unstructured":"Holick MF. Vitamin D: a millenium perspective. J Cell Biochem. 2003;88:296\u2013307.","journal-title":"J Cell Biochem"},{"key":"184_CR52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ecl.2010.02.007","volume":"39","author":"JW Pike","year":"2010","unstructured":"Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am. 2010;39:255\u201369. table of contents.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"184_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mrgentox.2016.01.005","volume":"798-799","author":"S Machado Cda","year":"2016","unstructured":"Machado Cda S, Venancio VP, Aissa AF, Hernandes LC, de Mello MB, Del Lama JE, et al. Vitamin D3 deficiency increases DNA damage and the oxidative burst of neutrophils in a hypertensive rat model. Mutat Res Genet Toxicol Environ Mutagen. 2016;798-799:19\u201326.","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"184_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0027-5107(01)00080-X","volume":"475","author":"M Chatterjee","year":"2001","unstructured":"Chatterjee M. Vitamin D and genomic stability. Mutat Res. 2001;475:69\u201387.","journal-title":"Mutat Res"},{"key":"184_CR55","first-page":"208","volume":"810","author":"J Reichrath","year":"2014","unstructured":"Reichrath J, Rass K. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update. Adv Exp Med Biol. 2014;810:208\u201333.","journal-title":"Adv Exp Med Biol"},{"key":"184_CR56","first-page":"282","volume":"810","author":"DD Bikle","year":"2014","unstructured":"Bikle DD. The vitamin D receptor: a tumor suppressor in skin. Adv Exp Med Biol. 2014;810:282\u2013302.","journal-title":"Adv Exp Med Biol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0184-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:01:36Z","timestamp":1684602096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0184-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0184-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"18 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}